EPCAM and head and neck squamous cell carcinoma: HNSSC (Squamous cell carcinoma of the head and neck) xenotransplanted severe combined immunodeficient (SCID) mice were treated with radioimmunotherapy against EpCAM positive cells and biodistribution of EpCAM-directed monoclonal antibodies were investigated in EpCAM-transgenic mouse models [17], [18].